New England Capital Financial Advisors’s TC BioPharm (Holdings) plc American Depositary Shares TCBP Stock Holding History

New England Capital Financial Advisors’s Portfolio TCBP Stock Details TCBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-13	Closed	-$130	–	422
2024 Q4	$130	Hold	13	–	–	﹤0.01%	398
2024 Q3	$1.06K	Buy	+13	New	+$1.32K	﹤0.01%	341

Other funds holding TCBP

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

New England Capital Financial Advisors's TCBP Position: Q1 2025 in Review

New England Capital Financial Advisors sold out of TC BioPharm (Holdings) plc American Depositary Shares (TCBP) in Q1 2025, closing a stake of 13 shares — an estimated $130 sold.

New England Capital Financial Advisors first reported a position in TCBP in Q3 2024 and held it in 2 quarters. The position peaked at $1.06K in Q3 2024. 2 funds tracked by Wall St. Rank hold TCBP as of Q1 2025.

New England Capital Financial Advisors reported no remaining TC BioPharm (Holdings) plc American Depositary Shares position as of Q1 2025 after selling out during the quarter.
New England Capital Financial Advisors sold 13 TC BioPharm (Holdings) plc American Depositary Shares shares in Q1 2025, an estimated $130.
New England Capital Financial Advisors first reported a position in TC BioPharm (Holdings) plc American Depositary Shares in Q3 2024 and held it in 2 quarters.
New England Capital Financial Advisors's TC BioPharm (Holdings) plc American Depositary Shares position peaked at $1.06K in Q3 2024.
2 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc American Depositary Shares as of Q1 2025.

Based on New England Capital Financial Advisors's 13F filing for Q1 2025, filed 5 May 2025.